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Prader–Willi syndrome (PWS), a genetic disorder of obesity, intellectual disability and sleep abnormalities, is
caused by loss of non-coding RNAs on paternal chromosome 15q11-q13. The imprinted minimal PWS locus
encompasses a long non-coding RNA (lncRNA) transcript processed into multiple SNORD116 small nucleolar
RNAs and the spliced exons of the host gene,116HG. However, both the molecular function and the disease rele-
vance of the spliced lncRNA 116HG are unknown. Here, we show that 116HG forms a subnuclear RNA cloud that
co-purifies with the transcriptional activator RBBP5 and active metabolic genes, remains tethered to the site of
its transcription and increases in size in post-natal neurons and during sleep.Snord116delmice lacking 116HG
exhibited increased energy expenditure corresponding to the dysregulation of diurnally expressedMtorand cir-
cadian genesClock,Cry1 andPer2. These combined genomic and metabolic analyses demonstrate that 116HG
regulates the diurnal energy expenditure of the brain. These novel molecular insights into the energy imbalance
in PWS should lead to improved therapies and understanding of lncRNA roles in complex neurodevelopmental
and metabolic disorders.
INTRODUCTION
Prader–Willi syndrome (PWS), one of the leading genetic
causes of obesity in children (1), is characterized by intellectual
disabilities, hyperphagia, sleep disorders and increased risk
for psychoses and autism (2). PWS is an imprinted dis-
order caused by paternal deletions of human chromosome
15q11-q13, whereas reciprocal maternal deletions cause the dis-
tinct neurodevelopmental disorder Angelman syndrome (3).
Parental imprinting is a non-Mendelian inheritance pattern influ-
enced by the sex of the parent because of gametic differences in
epigenetic marks such as DNA methylation (4). Human chromo-
some 15q11-q13 contains multiple maternally silent, paternally
expressed protein-coding genes and non-coding RNAs regulated
by an imprinting control region (ICR) (5), which when deleted is
sufficient to cause PWS (6).
Human genetic studies have defined the minimal functional
PWS gene locus to a cluster of non-coding RNAs within the
HBII-85/SNORD116, making PWS the first human disease
found to be caused by loss of non-coding RNA (7–9). The
SNORD116 region encodes repeated C/D box small nucleolar
RNAs (snoRNAs) (SNORD116) and a spliced long non-coding
RNA (lncRNA) host gene (116HG) that is stably retained in
the nucleus (10) (Fig. 1A). In human cells, an alternative RNA
species (sno-lncRNA) was recently described that binds the spli-
cing factor Fox2 (11), although the presence in mice of the
sno-lncRNA has not been confirmed and the relevance to the
phenotype of PWS is currently unknown. Mice with an engi-
neered deletion of the Snord116 repeat cluster (Snord116del) re-
capitulate the PWS phenotype of altered metabolism and growth
deficiency, although not obesity (12,13). In mice, the Snord116/
116HG transcript is expressed only in neurons, suggesting that
the metabolic phenotype is due to the central dysregulation of
energy use in the central nervous system.
While human and mouse genetics demonstrate the critical
nature of the SNORD116 locus in PWS, the presence of multiple
processed RNA products complicates a mechanistic understand-
ing. SNORD116/Snord116 repeats are adjacent to a set of
repeats called SNORD115/Snord115, encoding both 115HG
and SNORD115 RNA products. Both loci are transcribed as
part of the same primary transcript originating from the ICR,
but only loss of the SNORD116 region encoding the 116HG
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lncRNA is sufficient to cause PWS (7–9). While theSNORD115
snoRNA functions to regulate alternate splicing of a serotonin
receptor (14), the role of the spliced lncRNA 116HG has not
been investigated.
LncRNAs exert essential functions via diverse mechanisms,
including scaffolds for chromatin remodeling complexes
or decoys for nucleotide binding (15,16). Although many
lncRNAs such as 116HG are expressed in the brain, their role
in human disease, including PWS, is uncharacterized (17). Inter-
estingly, over 50 C/D box snoRNA host genes were unexpected-
ly identified in a recent genomic screen for diurnally regulated
transcripts in Drosophila (18), but the functional relevance of
snoRNA host genes in diurnal transcription is completely
unknown.
In this study, we use a combination of in situmolecular genet-
ics, genomic and whole-body metabolism approaches to func-
tionally characterize the lncRNA 116HG that emerges in the
brain in the first week of life as an RNA cloud in neuronal
nuclei. The transcriptional activator RBBP5 and 2403 active
metabolic genes were identified as significantly associated
with 116HG during the light phase, when Snord116del mice
exhibited dysregulation of diurnally expressed Mtor and circa-
dian genes Clock, Cry1 and Per2. Genome wide, over twice as
many genes in the light compared with the dark phase, showed
altered expression in Snord116del versus wild-type (WT)
mice, corresponding to the metabolic phenotype of the reduced
respiratory exchange ratio (RER) and the increased energy
expenditure in this PWS mouse model.
RESULTS
116HG forms a developmentally regulated lncRNA cloud
To understand the expression and localization of the 116HG
lncRNA in mammalian brain development, RNA fluorescence
in situ hybridization (FISH) using probes targeting the splice
junction of 116HG or 115HG (Fig. 1A) was performed on
mouse brain tissue, revealing two distinct cloud-like nuclear
domains in adult neuronal nuclei (Fig. 1B). In contrast,
Snord116del mouse brain showed the 115HG, but not the
116HG, lncRNA cloud (Supplementary Material, Fig. S1).
The 116HG and 115HG nuclear clouds observed were similar
to small ‘grape’ structures seen previously in primary neuronal
cultures (10), but covered a much larger area of the nucleus in
adult brain neurons. 116HG and 115HG nuclear clouds were
observed in neurons but not glia throughout brain regions of
hypothalamus, hindbrain, forebrain, cortex, hippocampus and
cerebellum, but not in cells of the liver or spleen (data not
shown). Both 116HG and 115HG lncRNA clouds significantly
increased in diameter during the first week of post-natal life
Figure 1. 116HG and 115HG are developmentally regulated and form overlapping but distinct nuclear RNA clouds. (A) Schematic representation of the murine PWS
locus. RNA FISH probes (red) and the DNA FISH probe (green) are shown. (B) RNA FISH for 115HG (green) and 116HG (red) on adult WT mouse cortex. 4′,6-
diamidino-2-phenylindole (blue), scale bar is 1 mm. (C) Diameters of RNA cloud signals on individual cortical sections from E19, P2, P5 and adult mice. (D)
Co-localization of 116HG and 115HG clouds. (E) Combined DNA and RNA FISH to adult mouse cortical tissue revealed partial co-localization of the 116HG
lncRNA (red) with the paternal decondensed allele of Snrpn through Ube3a (green). (F) Combined DNA and RNA FISH on human cerebellum from a neurotypical
female using human-specific RNA and DNA probes (see also Supplementary Material, Fig. S1).
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(Fig. 1C), and co-localization analysis revealed that 116HG and
115HG separated into overlapping but distinct lncRNA clouds in
the post-natal cortex (Fig. 1D). The increased size and separation
of 116HG and 115HG lncRNA clouds developmentally coin-
cided with the previously described nucleolar accumulation of
Snord116 snoRNAs and the large-scale chromatin decondensa-
tion of the paternal Snrpn-Ube3a locus containing the Snord116
repeat cluster (19).
Combined RNA and DNA FISH on the adult cortex revealed
that 116HG and 115HG localized to the paternal decondensed
allele of Snrpn-Ube3a (Fig. 1E and Supplementary Material,
Fig. S1). The Snord116 DNA overlapped with 116HG, but not
115HG, and the two DNA loci (Snord116 and Snord115) co-
localized in adult kidney, but not brain, nuclei (Supplementary
Material, Fig. S1) consistent with the neuronal tissue-specific
chromatin decondensation of this locus (19). Human-specific
RNA/DNA FISH probes confirmed that 116HG forms an
RNA cloud localized to the decondensed SNORD116 paternal
allele in postmortem human brain (Fig. 1F), showing the
relevance of the 116HG lncRNA cloud for understanding
human PWS.
116HG binds to RBBP5 and target loci genome wide
Other lncRNAs that form subnuclear RNA clouds, such as Xist
and Kcnq1ot1, bind proteins that regulate transcription of
target regions (15,16). In order to isolate 116HG-associated pro-
teins and interacting DNA from mouse brain, we adapted a
method called chromatin isolation by RNA purification
(ChIRP) (20–22) using biotinylated antisense oligos comple-
mentary to 116HG. Reverse transcriptase–quantitative poly-
merase chain reaction (RT–qPCR) on RNA isolated by ChIRP
showed 25–30% of input 116HG RNA was retrieved by
116HG-specific oligos but not by non-specific control (NSC)
oligos (Fig. 2A). Analysis of DNA isolated by ChIRP revealed
that Snord116 DNA was retrieved by 116HG-specific oligos
(Fig. 2B), confirming DNA FISH results (Fig. 1E). Immunoblot-
ting for candidate proteins interacting with 116HG revealed that
RBBP5 (but not MeCP2, Fox2 or Gapdh) was specifically
retrieved by 116HG ChIRP in an RNA-dependent manner
(Fig. 2C). RBBP5 is a subunit of the MLL1 complex that acti-
vates transcription through methylation of histone H3K4 and
interacts with the lncRNA Mistral to activate Hoxa6 and
Hoxa7 during stem cell differentiation (23). An in vitro tran-
scribed (IVT), biotinylated 116HG also retrieved RBBP5 in a
conformation-dependent manner, requiring slow-cooling fol-
lowing denaturation (Fig. 2D and Supplementary Material,
Fig. S2). An unbiased proteomic screen of 116HG ChIRP iden-
tified the Xist associating protein SAF-A(24), although SAF-A
association with 116HG was non-specific and not RNAse sensi-
tive (Supplementary Material, Fig. S2), unlike RBBP5.
Since the large size (.1.2 mm) of the116HG lncRNA nuclear
subdomain suggested that 116HG may interact in trans with
other gene loci, DNA isolated by ChIRP was analyzed by
next-generation sequencing (ChIRP-seq). Sequencing libraries
were made from ChIRP DNA samples from adult WT or
Figure 2. 116HG RNA interacts with RBBP5 and its endogenous locus. (A) qRT-PCR analysis of ChIRP RNA shows retrieval of 116HG lncRNA with a
116HG-specific probe, but not the NSC probe. (B) qPCR analysis of ChIRP DNA shows retrieval of Snord116 DNA with a 116HG-specific probe, but not the
NSC probe. (C) Western blotting of ChIRP proteins shows that116HG retrievedRBBP5 in an RNA-dependent manner,but not MeCP2, Fox2 or Gapdh. (D) Pull-down
of IVT biotinylated 116HG retrieved RBBP5 when allowed to renature under slow-cooling conditions but less efficiently in the unfolded state. (E) 116HGChIRP-seq
reveals peaks in theSnord116andSnord115 regions, which are absent in NSC ChIRP-seq samples. Top black track represents annotated genes. Blue represents116HG
ChIRP peaks and read coverage of 116HG ChIRP from WT brain (scale 0–50 reads). Green represents called peaks for merge of three control ChIRP experiments
(116HGChIRP on Snord116del+/2 brain and NSC ChIRP on WT and Snord116del+/2 brain) and read coverage from 116HGChIRP on Snord116del+/2 brain. Red
represents WT input. qPCR results graphed as the mean+SEM (see also Supplementary Material, Fig. S2).
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Snord116del+/2 mouse brain using 116HG-specific or NSC
oligos. As expected based on qPCR analysis (Fig. 2D) and
FISH (Fig. 1E and Supplementary Material, Fig. S1), 116HG
ChIRP-seq peaks from the WT brain were enriched at the
Snord116 and the Snord115 region (Fig. 2E) at levels compar-
able with published ChIRP methods (20).
In addition, analysis revealed 116HG-specific ChIRP peaks
associated with 2403 genes (Fig. 3A and Supplementary Mater-
ial, Fig. S2 and Supplementary Material, Table S1). Combined
RNA/DNA FISH experiments confirmed the enriched
co-localization of these ChIRP target genes with the 116HG
lncRNA cloud, compared with two negative control regions
(Fig. 3B and C). Gene ontology (GO) analysis revealed that
the 116HG-specific ChIRP genes were enriched for brain ex-
pression, protein transport, protein and chromatin modifications
and protein metabolic processes (Fig. 3D and E and Supplemen-
tary Material, Table S2). 116HG-specific ChIRP genes included
the mammalian target of rapamycin (Mtor), transcriptional regu-
lator Creb-binding protein (Crebbp) and imprinted insulin
growth factor receptor (Igf2r).
Loss of 116HG leads to up-regulation of genes
We investigated the effect of loss of 116HG on transcript levels
genome wide by comparing WT versus Snord116del+/2 mice
by RNA-seq analysis of the adult cortex. 6467 genes were sig-
nificantly altered (q-value of ,0.05) in the Snord116del com-
pared with the WT cortex, with 94.2% up-regulated in the
Snord116del cortex (Supplementary Material, Table S3). Com-
parison of Snord116del dysregulated genes to ChIRP-seq peaks
revealed that 50% (1201) of genes identified by ChIRP had
altered expression levels in the Snord116del cortex (Fig. 4A
and Supplementary Material, Table S4). GO analysis of genes
identified by ChIRP and RNA-seq analysis was enriched for
protein and cellular metabolic processes, chromatin modifica-
tion, cellular biosynthetic processes, neurogenesis and central
nervous system development (Supplementary Material,
Table S5). Most ChIRP peaks were located within genes or
distal to transcription start sites (TSSs) (Fig. 4B), suggesting
that 116HG association with target genes may be sequestering
RBBP5 away from promoter regions. qRT-PCR analysis
Figure3.116HGRNA binds to loci genome wide. (A)116HGassociates with distant loci. Blue track shows116HGChIRP peaks from the WT brain, while lower track
shows the absence of control ChIRP peaks at these gene loci. (B) Combined RNA and DNA FISH to adult mouse cortical tissue confirmed co-localization of the116HG
lncRNA (green) withCcdc12 andMtor loci (red). (C) Gene loci identified by116HGChIRP (black) showed greater overlap with116HG than negative control regions
(white). n ¼ 695 nuclei. (D and E) GO analysis of 116HG ChIRP identified genes (see also Supplementary Material, Fig. S3).
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confirmed the up-regulation of genes identified by RNA-seq
analysis in an independent set of mice (Fig. 4C). Combined,
these results suggest a decoy model in which 116HG prevents
RBBP5 binding to promoters of 116HG-associated genes,
similar to that described for lncRNA Gas5 and the glucocortic-
oid receptor (25).
The overlap of ChIRP-seq and RNA-seq results included
genes important for signal transduction and protein catabolism,
including the metabolic regulator Mtor. To further investigate
changes in mTOR signaling, WT and Snord116del+/2 brain
slices were immunostained for mTOR protein and for
phospho-S6, a downstream target of mTOR (26) (Fig. 4E
and F). The mTOR signal was increased and significantly
more cells were positive for phospho-S6 in the Snord116del
cortex compared with WT littermates (Fig. 4E), confirming
increased mTOR activity. mTOR up-regulation appeared to be
cortex-specific, as phospho-S6 staining was unchanged in
Snord116del hippocampus (Fig. 4E).
Snord116delmice show alteration of diurnally
regulated genes
mTOR activity is controlled by a circadian clock in the suprachi-
asmatic nucleus (26), and a prior study in WT C57/BL6 mice
revealed many cortical genes to be diurnally regulated (27).
Therefore, we investigated whether Snord116del loss had an
effect on transcription associated with diurnal time. WT and
Snord116del littermates were sacrificed at Zeitgeber (Zt) +6 h
and Zt +16 for RNA-seq analysis of cortical transcripts. At
Zt +6, 6467 genes were altered in the Snord116del cortex
(Fig. 5A), but at Zt +16 only 3140 transcripts changed
(Fig. 5B and Supplementary Material, Table S6). Genes
altered in the Snord116del cortex at Zt +6 significantly over-
lapped with genes previously described to be diurnally regulated
(27) as well as genes identified in our analysis as significantly
changed in WT mice at Zt +6 compared with Zt +16 (Supple-
mentary Material, Fig. S3). Dendrogram analysis of gene
Figure 4. Combined analysis of 116HG ChIRP-seq with RNA-seq of WT versus Snord116del cortex reveals up-regulation of 116HG bound genes including Mtor.
(A) Genes associated with 116HG-specific ChIRP peaks overlapped significantly with genes showing transcript level changes by RNA-seq. (B) 116HG binding sites
show clustering 5–500 kb up or downstream from transcription start sites. (C) qRT-PCR confirms significant up-regulation of 3/5 genes identified by RNA-seq:Mtor
(P ¼ 0.042),Arr3 (P ¼ 0.049),Mertk (P ¼ 0.007) in a larger set of WT (n ¼ 6) andSnord116del (n ¼ 12) mouse cortex. (D) Immunofluorescence staining of WT and
Snord116del prefrontal cortex for mTOR showing increased expression in Snord116del. (E) Laser scanning cytometry quantitation of phospho-S6 staining of WT
(black, n ¼ 3) compared with Snord116del (grey, n ¼ 3) for total brain slice, cortex or hippocampus. (F) Immunofluorescence staining of WT and Snord116del
cortex for phospho-S6.
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expression revealed that WT andSnord116del from Zt+16 were
more closely related than WT and Snord116del from Zt +6
(Fig. 5C). qRT-PCR confirmed the significant increase in diur-
nally regulated Cry1, Clock, Per2 and Mtor transcripts specific-
ally at Zt +6 (Fig. 5D). Furthermore, 116HG and 115HG
lncRNA clouds were significantly smaller in the cortex of WT
mice at Zt +16 when compared with Zt +6, revealing that
these nuclear lncRNA subdomains dynamically change with
diurnal time (Fig. 5E).
Snord116delmiceare leanandhave increased lipid oxidation
during light hours
We sought to relate altered diurnal transcript levels to the meta-
bolic phenotype of adult Snord116del mice (12), which were
previously shown to have lower body weight, fat mass and
lean mass compared with WT littermates (Fig. 6A and B).
Mice were continuously monitored in Comprehensive Lab
Animal Monitoring System (CLAMS) metabolic chambers for
a period of 6 days in order to measure their metabolism, food
intake and activity.Snord116delmice did not differ from WT lit-
termates in their food intake or activity (Fig. 6C and Supplemen-
tary Material, Fig. S4). However, Snord116del mice exhibited a
significant decrease in the RER compared with WT littermates
during light hours (Fig. 6D and Supplementary Material,
Fig. S4). The RER reflects the relative source of energy for the
animal with values closer to 1 representing increased carbohy-
drate oxidation and values closer to 0.7 representing increased
fat oxidation. An increase in the RER occurs during dark com-
pared to light hours in both WT and Snord116del mice
(Fig. 6D), consistent with increased food intake and activity
during dark hours (Supplementary Material, Fig. S4). In contrast
to WT mice,Snord116delmice have decreased RER during light
hours, which explain the decreased fat mass and body weight in
Snord116del mice (Supplementary Material, Fig. S4).
Snord116del mice also showed increased energy expenditure
compared with WT mice during both light and dark hours
(Fig. 6E). However, energy expenditure is dependent on body
weight, and analysis of covariance revealed that the increased
energy expenditure was not independent of body weight.
During light hours, WT mice reduce their energy expenditure,
decrease catabolism and increase anabolism (28). Snord116del
did show the expected diurnal cycling of their RER, energy ex-
penditure, activity and feeding (Fig. 6C–E and Supplementary
Material, Fig. S4), suggesting that their central circadian clock
is not disrupted and that the metabolic phenotype is due to the
central dysregulation of energy expenditure, not changes in
feeding or activity. Our results suggest that a key feature of
the Snord116del phenotype is altered the regulation of
diurnal energy source due to loss of 116HGmodulation of diur-
nally regulated circadian and metabolic genes during light
hours.
Figure5.Snord116delmiceshow altered transcript levels of diurnally regulatedgenes and RERduring light hours. (A) RNA-seqshowsup-regulation of manygenes at
Zt +6 in Snord116del versus WT cortex, and (B) fewer genes changed at Zt +16 in Snord116del versus WT cortex. The number of significant genes labeled in each
graph. (C) Dendrogram-based analysis of gene expression from samples in RNA-seq analysis. (D) Diurnally regulated genes were up-regulated at Zt +6 and down-
regulated at Zt+16 inSnord116delversus WT cortex. Transcript levels were normalized toGapdh, and fold change from WT graphed as the mean+SEM. For Zt+6
timepoint, n ¼ 6 WT, 12 Snord116del+/2. For Zt +16, n ¼ 5 WT, 6 Snord116del+/2. Zt +6 Clock (P ¼ 0.037), Cry1 (P ¼ 0.035), Per2 (P ¼ 0.010), Mtor (P ¼
0.042). Zt +16 Cry1 (P ¼ 0.019), Cry2 (P ¼ 0.007), Per1 (P ¼ 0.022). (E) 116HG (P ¼ 0.016) and 115HG (P ¼ 1.3 × 10205) lncRNA clouds are significantly
smaller at Zt +16 compared with Zt. +6. n ¼ 720 nuclei and 3 biological replicates per sample (see also Supplementary Material, Fig. S3).
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DISCUSSION
While the loss of the Snord116 locus was first hypothesized 10
years ago to be responsible for the pathogenesis of PWS (29), re-
search has focused on the roles of the orphan snoRNAs,
SNORD116 and SNORD115, and editing of the serotonin recep-
tor (5htrc) by SNORD115 (14). However, our results show that
the flanking snoRNA host exons form a functional lncRNA
structure, 116HG, which regulates the transcription of genes im-
portant for the regulation of diurnal transcription and metabol-
ism. Our work, therefore, provides a novel explanation that
loss of a specific lncRNA alters circadian energy homeostasis
in PWS. In humans, the SNORD116 locus gives rise to
sno-lncRNA in addition to 116HG (11). Although arising from
the same primary transcript, 116HG and sno-lncRNA act via in-
dependent mechanisms. In our studies, we used an RNA FISH
probe spanning an exon–exon boundary that is not present in
sno-lncRNA and did not observe an interaction of Fox2 with
116HG (Fig. 2C). Furthermore, there is no evidence within the
mouse genomic sequence for the existence of sno-lncRNA, sug-
gesting that the metabolic phenotype seen in the Snord116del
mice is due to loss of 116HG. However, future studies will
need to identify which of the RNAs generated from the
Snord116 locus are critically lost in PWS, and if loss of multiple
RNAs underlies the complex phenotype of PWS.
Sleep problems in PWS patients, including longer latency
and shorter duration of night-time sleep and excessive
daytime sleepiness, are consistent with a disruption in circadian
metabolism being central to the disease phenotype, rather than a
result of obesity (30). A mouse model of Magel2 deficiency, a
gene missing in PWS patients with large deletions, also
showed deficits in circadian rhythms (31), but the observations
reported here link circadian imbalances in the PWS critical
locus mouse model directly to loss of a lncRNA. The identi-
fication of over 50 C/D box snoRNA host genes of unknown
function identified in a Drosophila screen for diurnally
regulated transcripts (18) suggests that the diurnal regulation
of an snoRNA host gene is evolutionarily conserved. Since
lncRNAs can act to regulate the transcription of domains of
multiple genes (16), 116HG may coordinate the transcriptional
levels of multiple genes that have diurnal variation in expres-
sion. In this study, we have identified a group of 1201 genes
that are both significantly associated with 116HG and signifi-
cantly up-regulated in the absence of 116HG, suggesting a
Figure6.Snord116delmice are leaner than WT littermates and have increased lipid oxidation during light hours. (A)Snord116del+/2 gain weight at a slower rate than
WT littermates and (B) are smaller as adults corresponding to decreased fat mass, lean mass and total body weight. (C)Snord116del+/2 do not have altered food intake
compared with WT littermates during light or dark hours. (D) Snord116del+/2 mice exhibit lower RER during light hours when compared with WT mice.
(E) Snord116del+/2 mice have increased energy expenditure during light and dark hours (see also Supplementary Material, Fig. S4). Results are shown for male
mice (n ¼ 14 per group in A; WT, n ¼ 12; Snord116del, n ¼ 14 for B–E).
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direct transcriptional regulation by the 116HG cloud during the
light phase.
Disruption of sleep and diurnal rhythms of feeding in mice and
humans is associated with metabolic disorders that can lead to
either increased weight gain (32) or protection from obesity
(33). While hyperphagia in PWS is a key aspect of the phenotype
and contributes to a large extent to the obesity, infants with PWS
do not have increased caloric intake, but they do have increased
weight gain (34). A previous study of the Snord116del mice
found that they had increased food intake when compared with
WT littermates (12); however, in that study, food intake was nor-
malized tobodyweight and the relative increasewas dependenton
lower body weights in Snord116del mice. In our study, we found
no evidence for hyperphagia inSnord116delmice relative to body
weight or lean mass. Instead, we found that Snord116del mice do
not differ from WT mice in their food intake and that the lean
phenotype that has been reproduced across two mouse models
(12,13) is driven by dysregulated energy expenditure and meta-
bolic fuel source. This finding indicates that a key mechanism in
the pathogenesis of PWS is loss of energy balance due to loss of
the non-coding RNAs from the Snord116 region.
Furthermore, in human PWS, weight increases before the onset
of hyperphagia or increased food intake (34), supporting the hy-
pothesis that a primary factor in the onset of obesity in PWS is
loss of energy regulation. In mice, diurnal rhythms become estab-
lished near post-natal day 10 (35). A previous study of gene ex-
pression in Snord116del mouse hypothalamus found no changes
in gene expression during the first 2 weeks of life (36), which
could be due to immature establishment of diurnal rhythms at
the timepoints analyzed. In contrast, our study investigated the
Snord116del cortex in adulthood when diurnal rhythms are estab-
lished and the greatest differences in metabolism and weight are
seen when compared with WT littermates. In humans, diurnal
rhythms begin to appear at 1 month after birth and become estab-
lished over the first year of life (37). The establishment of diurnal
rhythms during infancy may relate to the phenotypic switch
observed in PWS from one of early failure-to-thrive in infancy
to later obesity and altered metabolism (34).
MATERIALS AND METHODS
Animal care
B6(Cg)-Snord116tm1.1Uta/J (Snord116del) mice were obtained
from Jackson Labs (Bar Harbor, ME, USA) and housed in a
24-h light/dark cycle (6 a.m.–6 p.m. light, 6 p.m.–6 a.m.
dark), temperature controlled room and fed a standard diet of
Picolab mouse chow 20 (PMI International, St Louis, MO,
USA). Animal genotyping was performed using PCR from tail
DNA as described previously (19). Heterozygous deletion
male mice were bred with C57BL/6 WT females to generate
paternal deletion Snord116del+/2 and WT littermates.
Human tissue
Human postmortem cerebellum of brain 1209 was received
frozen and was fixed in 10% formalin, embedded and sectioned
(5 mm). Tissue was obtained through the NICHD Brain and
Tissue Bank for Developmental Disorders located at the Univer-
sity of Maryland School of Medicine.
Mouse tissue
For RNA, DNA and RNA/DNA FISH analyses, tissue was pre-
pared as described previously (19). For the oligo-based purifica-
tion of RNA-associated proteins and in vitro biotinylated RNA
pull-down of proteins, one hemisphere of a WT adult C57BL/6
brain was fixed in 3.7% formaldehyde/1× phosphate buffered
saline (PBS) and homogenized. Nuclei were resuspended in
RNA immunoprecipitation/formamide buffer [150 mM KCl,
25 mM Tris–HCl, pH 7.5, 5 mM ethylenediaminetetraacetic
acid (EDTA), 0.5% NP-40, 10% formamide with Superasin
(Ambion) and complete proteinase inhibitors (Roche) added].
For ChIRP, one hemisphere of a WT adult C57BL/6J or
Snord116del brain was fixed in 3.7% formaldehyde/1× PBS
and homogenized. Nuclei were resuspended in ChIRP lysis
buffer (50 mM Tris–HCl, pH 7.5, 10 mM EDTA, 1% sodium
dodecyl sulfate +Superasin and proteinase inhibitors). For
RNA-sequencing analysis, the brains from adult Snord116del
and WT littermates were collected and cortices were dissected
and placed in RNALater (Ambion) before RNA isolation.
RNA FISH and DNA FISH
FISH was performed as described previously (19). Overlap of
RNA FISH clouds was analyzed by first outlining the area of
115HG and then scoring for complete, partial or no signal
from116HGwithin the area defined by115HG. DNA FISH mea-
surements were taken using a 100 × oil objective with a 2 ×
zoom and pixel counts converted to micron distance. All mea-
surements for a given experiment were taken with the same ex-
posure times and microscope settings appropriate for the
fluorescence intensity. RNA FISH on human postmortem cere-
bellum samples was performed using custom directly labeled,
single-stranded oligo library synthesis probes (Agilent). Signifi-
cant changes tested by two-tailed Student’s t-test.
RNA/DNA FISH
Slides were prepared as for RNA FISH and hybridized with
locked nucleic acid probes (Exiqon) overnight at 468C and
washed 3× in 50% formamide/2× saline-sodium citrate
(SSC) and 2× in 2× SSC at 468C, fixed with 3.7% formalde-
hyde/1× PBS at RT for 5 min, washed in 1× PBS and dehy-
drated through a series of ethanol washes (50, 70, 90 and
100%). DNA FISH probes were then applied and slides were
denatured for 3 min at 858C. Washing and detection was per-
formed as for RNA or DNA FISH alone.
Immunofluorescence and laser scanning cytometry
Immunofluorescence and laser scanning cytometer (LSC) ana-
lysis was performed as described previously (19).
Microscopy
Slides were analyzed on an Axioplan 2 fluorescence microscope
(Carl Zeiss, Inc., NY, USA) equipped with a Qimaging Retiga
EXi high-speed uncooled digital camera, appropriate fluorescent
filter sets and automated xyz stage controls. Images were cap-
tured with appropriate filter sets at 0.1 mm sections and multiple
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Z-slices were combined for final images. For phospho-S6 quan-
tification, slides were scanned on a laser scanning cytometer
(CompuCyte) with a 20× objective. Nuclei were contoured
using 4′,6-diamidino-2-phenylindole fluorescence, the contours
extended by 15 pixels, and cells were gated for fluorescence
above background. All slides were scanned on identical
voltage, photomultiplier tube and threshold settings. Brain
regions were partitioned based on the composite image from
all scan fields. Significant changes tested by Student’s t-test.
Oligo purification of RNA-bound proteins
200 pmol of biotinylated DNA oligos (Invitrogen) were added to
1 mg of material and incubated at 48C for 4 h. C-1 streptavidin
beads (Invitrogen) were used to retrieve biotinylated DNA
oligos with hybridized RNA:protein complexes. Proteins were
analyzed by immunoblotting. For RNAse sensitivity, Superasin
was omitted and 10 mg of RNAse A (Ambion) was added to soni-
cated material and incubated at 378C for 30 min before biotiny-
lated probe was added. For mass-spec identification, proteins
were run on an sodium dodecyl sulfate–polyacrylamide gel
electrophoresis gel and stained with Imperial protein stain. A
1 cm square piece of gel from 80–140 kDa was excised and
submitted to the UC Davis Proteomics core for mass-spec
identification.
In vitro biotinylated RNA pull-down of proteins
Template DNA was linearized and 250 ng of DNA was IVT
using Biotin RNA labeling Mix (Roche), DNAse I (NEB)
treated and nucleotides removed using Micro-Biospin columns
(Biorad). IVT RNA was denatured at 658C for 5 min and then
slow-cooled to 48C. RNA was quantified using a Nanodrop spec-
trophotometer, 100 pmol RNA was added to 1 mg of lysate and
incubated for 2 h at RT. C-1 streptavidin beads were used to re-
trieve biotinylated RNA and bound proteins were analyzed by
immunoblotting.
Antibodies
Primary antibodies: anti-GAPDH clone 6C5 (Advanced Immu-
nochemical), anti-RBBP5 (Bethyl), anti-MeCP2 (Cell Signal-
ing), anti-FOX2, anti-histone H3-total (Abcam), anti-SAF-A/
HNRNP-U (Novus Biologicals) and anti-Ezh2 (Active Motif).
Secondary antibodies: GARIG-Alexa-488 (Life Technologies),
anti-DIG-Alexa-488, anti-biotin-Rhodamine (Jackson), GARIG-
HRP and GAM-HRP (Biorad).
Chromatin isolation by RNA purification
Brain cell lysate was sonicated on high in a Bioruptor sonicator
(Diagenode) at 48C until solution was no longer turbid and size
of fragments was 200–800 bp by gel analysis. Insoluble mate-
rial was pelleted by centrifugation at 16 000g for 5 min at 48C.
100 ml was saved as input for DNA purification and 100 ml for
RNA purification. ChIRP was performed as described previous-
ly (20). 10 ml of eluted DNA was used to prepare sequencing li-
braries using NuGEN Ovation Ultralow Library kit following
the manufacturer’s instructions for multiplexing with barcodes
L2DR-BC1-8.
RNA-sequencing
RNA was purified from dissected cortices using RNEAsy
columns (Qiagen) following the manufacturer’s instructions
and analyzed on a Bioanalyzer. Samples with an RNA integrity
number. 7 were used to prepare libraries using the NuGEN
Encore Complete RNA-seq library kit following the manufac-
turer’s instructions for multiplexing, with cDNA fragmentation
performed on a Bioruptor for 1 h at 48C. Three WT males from Zt
+6, two WT males from Zt +6, two Snord116delmales from Zt
+6 and two Snord116del males from Zt +16 were analyzed.
Next-generation sequencing
Sequencing libraries for ChIRP-sequencing and RNA-
sequencing were analyzed for quality on a Bioanalyzer
(Agilent) and were sequenced on a Hi-seq-2000 at the Vincent
J. Coates Genomics Sequencing Laboratory at UC Berkeley.
ChIRP-sequencing data analysis
ChIRP-sequencing reads were aligned using Bowtie2 against the
Musmusculusmm9genome, and peaks were called using model-
based analysis for ChIP-Seq (MACS) (38,39). The numbers of
aligned reads out of total reads for each sample were
WT-116HG-ChIRP-1: 29,814,977/42,110,162; WT-116HG-
ChIRP-2: 22,522,642/91,706,595; WT-NSC-ChIRP: 29,064,
400/41,230,076; Snord116del-116HG-ChIRP: 38,787,232/40,
374,703; Snord116del-NSC ChIRP: 48,493,474/50,605,786;
Input: 23,704,637/25,610,883. MACS identified peaks from
ChIRP were filtered by the false discovery rate (,5%) and
fold-enrichment over input (.20). Since no sequence motifs
were identified using all the called 116HG ChIRP peaks from
two biological replicates, we used a 10 kb window to identify
peaks that appeared in the same genomic region in both
WT-116HGChIRP samples. 8105 MACS identified peaks repli-
cated between the two WT-116HG ChIRP samples. In contrast,
of 8300 MACS-called peaks combined from the three negative
control ChIRP samples (WT-NSC, Snord116del-116HG and
Snord116del-NSC), there was ,0.05% overlap between sam-
ples and only 985 peaks were within 10 kb of 116HG-ChIRP
identified peaks. The BED file with corresponding confident
peaks was then used to generate an associated gene list by
mapping to closest gene within 2 kb of the 8105 replicated
peaks. Genes associated with 116HG peaks were submitted
for DAVID GO analysis (40,41). ChIRP peaks were mapped
relative to TSS using Genomic Regions Enrichment of Annota-
tions Tool (GREAT) http://bejerano.stanford.edu/ (42).
RNA-sequencing data analysis
Reads were aligned against the Mus musculus mm9 genome
using Tophat2 with a reference gene transfer format guide.
Reads per sample were: WT-Zt6-1 56,801,996, WT-Zt6-2
64,288,201, WT-Zt6-3 63,022,540, Snord116del-Zt6-1 53,278,
255, Snord116del-Zt6-2 40,243,885, WT-Zt16-1 63,985,980,
WT-Zt16-2 56,483,862, Snord116del-Zt16-1 54,310,542 and
Snord116del-Zt16-2 61,584,399. Cuffdiff was used to identify
significant changes of transcript levels between paternal in-
herited Snord116del+/2 and WT mice (43) with a q-value of
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,0.05. CummeRbund was used to extract cuffdiff data for gene
lists identified by ChIRP and to generate plots for figures (27,43).
The chi-squared test used to identify the enrichment of signifi-
cantly changed genes overlapped between Zt6 WT/Snord116del
changed genes and the ChIRP-seq gene set (P ¼ 2.2 × 10216),
the diurnally regulated gene set (P ¼ 2.2 × 10216) and the WT
Zt6/Zt16 gene set (P ¼ 2.2 × 10216).
Metabolic chamber analysis
Mice were placed in Oxymax/CLAMS (Columbus Instruments)
at the UC Davis Mouse Metabolic Phenotyping Center and mon-
itored for 7 days with six full 24-h light/dark cycles. Only male
Snord116del+/2 mice were analyzed by CLAMS. Locomotion,
food and water intake, O2 consumption and CO2 emission were
automatically monitored. To allow the acclimation of mice to
CLAMS chambers only the final four full light/dark cycles
were used in analysis of energy expenditure. Significant
changes tested by two-tailed Student’s t-test.
Body weight and percent fat
After being removed from CLAMS chambers, mice were
weighed, anesthetized with isofluorane and scanned using dual
energy X-ray absorptiometry (Piximus, Fitchburg WI, USA).
qPCR
qPCR analyses were performed using Sybr Green (Bioline) on an
ABi ViiiA 7 in 384-well formats with custom primers (Supple-
mentary Material, Table S7). Significant changes tested by the
Mann–Whitney U-test.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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